Method of treating migraine

• US 5,977,145 A
• Filed: 02/12/1998
• Issued: 11/02/1999
• Est. Priority Date: 02/12/1998
• Status: Expired due to Fees

• Current Assignee: Akorn Incorporated (Akorn Holdings Topco LLC)
• Original Assignee: Taylor Pharmaceuticals, Inc.
• Inventors: Young, William B., Silberstein, Stephen D.
• Primary Examiner(s): Spivack, Phyllis G.
• Application Number:
  US09/022,312
• Time in Patent Office: 628 Days
• Field of Search: 514/338
• US Class Current: 514/338
• CPC Class Codes: A61K 31/44 Non condensed pyridines; Hydrogenated derivatives thereof

Abstract

Intravenous or intramuscular injection of droperidol is disclosed to treat migraine episodes.

Claims

1. A method of treating a migraine episode in a patient comprising administering droperidol, either intravenously or intramuscularly, to a patient that is experiencing a migraine episode, in an amount that is effective to treat symptoms of migraine.

2. The method of claim 1 in which from about 2.5 to about 10 mg of droperidol is administered to the patient.

3. The method of claim 2 in which the administration is intravenous.

4. The method of claim 2 in which the administration is intramuscular.

5. The method of claim 3 in which the patient failed to respond to other migraine therapy prior to receiving droperidol.

6. The method of claim 4 in which the patient failed to respond to other migraine therapy prior to receiving droperidol.